|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
1.010 +0.010 (+1.000%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Turnover | 810,002 | 13.300% | 714,918 | 817,353 | 750,413 | 695,425 |
| Cost of Sales | (458,531) | 10.799% | (413,839) | (476,924) | (477,571) | (429,168) |
| Gross Profit | 351,471 | 16.737% | 301,079 | 340,429 | 272,842 | 266,257 |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 129 | -61.145% | 332 | (2,018) | (2,100) | (3,312) | |
| Profit / (Loss) before Taxation | 175,377 | 47.549% | 118,860 | 176,768 | 101,906 | 127,813 | |
| Taxation | (35,087) | 62.598% | (21,579) | (29,400) | (19,047) | (15,363) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 80,609 | -- | -- | 3 | |
| Non-controlling Interests | 0 | -- | (23,850) | (11,176) | (2,820) | (9,940) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 140,290 | -8.926% | 154,040 | 136,192 | 80,039 | 102,513 | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Net Finance Costs / (Income) | 13,626 | -56.757% | 31,510 | 18,960 | 11,984 | 14,491 |
| Depreciation & Amortisation | 71,464 | 0.085% | 71,403 | 92,711 | 97,582 | 88,952 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | 7.070 | -12.283% | 8.060 | 7.100 | 4.180 | 5.350 |
| DPS (cts) | 3.500 | -- | 2.500 | 2.800 | 1.200 | 0.800 |
| Dividend Payout Ratio (%) | 49.505% | -- | 31.017% | 39.437% | 28.708% | 14.953% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.216 | -- | 1.179 | 1.307 | 1.258 | 1.366 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 140,290,000 |
| %Change | -8.926% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 1.216 |